微博
加入微博一起分享新鲜事
登录
|
注册
140
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials https://icostatistics.no/publication/jorgensen-efficacy-2020/
请登录并选择要私信的好友
300
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials https://icostatistics.no/publication/jorgensen-efficacy-2020/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候